939981-37-0,
p53 and MDM2 proteins-interaction-inhibitor chiral,
p53 and MDM2 proteins-interaction-inhibitor (chiral),
CHEMBL2386350,
p53 and MDM2 proteins-interaction-inhibitor (racemic),
SCHEMBL3541481,
DTXSID40590834,
BDBM50434283,
ZINC68078924,
CS-0332,
NCGC00378588-02,
HY-70027,
FT-0772814,
W-5579,
2-(4-((4R,5S)-2-(4-(tert-Butyl)-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimehyl-4,5-dihydro-1H-imidazole-1-carbonyl)piperazin-1-yl)-1-morpholinoethanone,
2-[4-[[(4S,5R)-4,5-Bis(4-chlorophenyl)-2-[4-(1,1-dimethylethyl)-2-ethoxyphenyl]-4,5-dihydro-4,5-dimethyl-1H-imidazol-1-yl]carbonyl]-1-piperazinyl]-1-(4-morpholinyl)ethanone,
2-{4-[(4S,5R)-2-(4-tert-Butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethyl-4,5-dihydro-1H-imidazole-1-carbonyl]piperazin-1-yl}-1-(morpholin-4-yl)ethan-1-one,
DJZBZZRLUQDRII-IOLBBIBUSA-N,
p53 and MDM2 proteins-interaction-inhibitor racemic,
A3693,
A15201,
939983-14-9,
2-[4-[[(4R,5S)-4,5-bis(4-chlorophenyl)-2-[4-tert-butyl-2-ethoxyphenyl]-4,5-dihydro-4,5-dimethyl-1H-imidazol-1-yl]carbonyl]-1-piperazinyl]-1-(4-morpholinyl)-ethanone,